Cubbie Conference December 10, 2026 in San Francisco Get tickets →

AI-powered genomic interpretation platform from Illumina that automates variant prioritization and case reporting.

Pricing

Custom quote

Founded

2016

Team size

51-200 employees

Headquarters

Tel Aviv, Israel

At a glance

Pricing model

Custom quote

Try before you buy

About Emedgene

Emedgene is a genomic interpretation platform, now offered by Illumina, that automates germline variant interpretation, prioritization, curation and research-report generation from sequencing and microarray data. Powered by explainable AI, it can cut interpretation time per sample by 50-75% and integrates with Illumina's DRAGEN, BaseSpace and Connected Analytics. It is aimed at clinical and research genomics labs, especially for rare-disease analysis.

Buyer Fit & Positioning

Procurement & Fit

Structured facts from the vendor to help your security, finance, and procurement reviews move faster.

Trust

Security & compliance

The vendor hasn’t added security or compliance details yet.

Pricing

Commercial model

Pricing model: Custom quote

Free trial: Yes

Free plan: No

Contract minimum: Not specified

Procurement

Purchasing & legal

The vendor hasn’t added purchasing & legal details yet.

Fit

Best-fit company size

Company-size fit has not been specified yet.

Implementation & Procurement

Commercial Fit & Ecosystem

Proof, Outcomes & Momentum

Alternatives, Migration & Buyer Objections